今开:5.02 | 昨收:5.17 |
最高:5.47 | 最低:5.02 |
涨停价:0.0 | 跌停价:0.0 |
总市值:2.905165E7 |
Aprea Therapeutics(APRE)02-14 21:05
$Aprea Therapeutics(APRE)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001214659-24-002595 Act: 34 Size: 41 KB 网页链接查看全文
Aprea Therapeutics(APRE)02-05 19:05
$Aprea Therapeutics(APRE)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001104659-24-010200 Act: 33 Size: 216 KB 网页链接查看全文
Aprea Therapeutics(APRE)02-07 06:05
$Aprea Therapeutics(APRE)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001558370-24-000818 Act: 34 Size: 6 MB 网页链接查看全文
Aprea Therapeutics(APRE)03-26 20:25
$Aprea Therapeutics(APRE)$ 8-K Current report, items 2.02, 8.01, and 9.01 Accession Number: 0001558370-24-003887 Act: 34 Size: 6 MB 网页链接查看全文
Aprea Therapeutics(APRE)03-29 06:05
$Aprea Therapeutics(APRE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-040645 Size: 7 KB 网页链接查看全文
Aprea Therapeutics(APRE)03-15 08:55
$Aprea Therapeutics(APRE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-034671 Size: 10 KB 网页链接查看全文
Aprea Therapeutics(APRE)03-15 09:05
$Aprea Therapeutics(APRE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-034673 Size: 10 KB 网页链接查看全文
Aprea Therapeutics(APRE)04-25 19:25
$Aprea Therapeutics(APRE)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001558370-24-005683 Act: 34 Size: 348 KB 网页链接查看全文
Aprea Therapeutics(APRE)02-05 19:05
$Aprea Therapeutics(APRE)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-24-000309 Act: 33 Size: 1 KB 网页链接查看全文
智通财经APP获悉,9月21日(周二)美股开盘,三大指数齐涨。道琼斯指数涨0.38%;纳斯达克综合指数涨0.50%;标普500指数涨0.46%。 个股消息 Aprea Therapeutics(APRE.US)盘初涨2.89%,旗下在研药物1/2期临床试验数据公布。 壳牌(RDS.A.US)... 网页链接
智通财经APP获悉,9月21日(周二)美股盘前,截至北京时间16:35,Aprea Therapeutics(APRE.US)涨18.35%,报5.74美元/股。消息面上,该公司在2021年欧洲肿瘤内科学会年会(ESMO)上,公布了在研药物突变抑制Eprenetapopt用于治疗晚期实体肿... 网页链接
【行情】生物制药公司Aprea Therapeutics(APRE.O)上涨14%,此前美国食品药品监督管理局批准其孤儿药用于白血病治疗。(美港电讯) 生物制药公司Aprea Therapeutics(APRE.O)上涨14%,此前美国食品药品监督管理局批准其孤儿药用于白血病治疗。 网页链接
$Aprea Therapeutics(APRE)$ ARS Annual Report to Security Holders Accession Number: 0001558370-24-005684 Act: 34 Size: 2 MB 网页链接
$Aprea Therapeutics(APRE)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001558370-24-005683 Act: 34 Size: 348 KB 网页链接
$Aprea Therapeutics(APRE)$ DEF 14A Other definitive proxy statements Accession Number: 0001558370-24-005678 Act: 34 Size: 1 MB 网页链接
$Aprea Therapeutics(APRE)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001558370-24-004927 Act: 34 Size: 7 MB 网页链接
$Aprea Therapeutics(APRE)$ S-3 Registration statement under Securities Act of 1933 Accession Number: 0001104659-24-043099 Act: 33 Size: 465 KB 网页链接
$Aprea Therapeutics(APRE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-040642 Size: 9 KB 网页链接
$Aprea Therapeutics(APRE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-040645 Size: 7 KB 网页链接
$Aprea Therapeutics(APRE)$ 8-K Current report, items 2.02, 8.01, and 9.01 Accession Number: 0001558370-24-003887 Act: 34 Size: 6 MB 网页链接
$Aprea Therapeutics(APRE)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001558370-24-003886 Act: 34 Size: 9 MB 网页链接
$Aprea Therapeutics(APRE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-034673 Size: 10 KB 网页链接